ReviewLung Cancer (Auckland, N.Z.)2019

Immune Checkpoint Inhibitors for the Treatment of Unresectable Stage III Non-Small Cell Lung Cancer: Emerging Mechanisms and Perspectives.

Hiroyuki Inoue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.